Humira Pen 80 MG/0.8 ML - Starter Package for Pediatric Ulcerative Colitis (4 count)

RxCUI
2531134
RxNorm name
Humira Pen 80 MG/0.8 ML - Starter Package for Pediatric Ulcerative Colitis (4 count)
Display name
Humira Pen 80 MG/0.8 ML - Starter Package for Pediatric Ulcerative Colitis (4 count)
Full name
Humira Pen 80 MG/0.8 ML - Starter Package for Pediatric Ulcerative Colitis (4 count)
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:00

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125057Humiraadalimumab351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
HumiraADALIMUMABAbbVie Inc.608d4f0d-b19f-46d3-749a-7159aa5f933d2025-12-23Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2531134

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
608d4f0d-b19f-46d3-749a-7159aa5f933d{4 (0.8 ML adalimumab 100 MG/ML Auto-Injector [Humira]) } Pack [Humira Pen 80 MG/0.8 ML - Starter Package for Pediatric Ulcerative Colitis] [BPCK] · Humira Pen 80 MG/0.8 ML - Starter Package for Pediatric Ulcerative Colitis (4 count) [PSN] · Humira Pen 80 MG/0.8 ML - Starter Package for Pediatric Ulcerative Colitis (4 count) [SY]32154These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing information for HUMIRA. HUMIRA ® (adalimumab) injection, for subcutaneous use Initial U.S. Approval: 200220251223